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Supplemental Figure legends 
Supplemental Figure 1. Body weight and glucose tolerance in Pemt+/+, Pemt+/-, 
Pemt-/- mice under standard (STD) and high fat-high sucrose (HFHS) diets. a. Body 
weight of Pemt+/+, Pemt+/-, Pemt-/- mice under STD and HFHS diets. n=8-26. b and c. 
Epididymal fat (b) and liver weight (c) of Pemt+/+, Pemt+/- and Pemt-/- mice at 25 weeks of 
age. n=5-9. d-g. Glucose tolerance test at 12 weeks of age (1.5 mg/kg BW i.p.). n=6-13. h 
and i. Insulin tolerance test at 12 weeks of age (0.75 IU/kg for STD and 1.0 IU/kg BW for 
HFHS i.p.). n = 5-9. All values are presented as mean ± SE. *P < 0.05, **P < 0.01 versus 
Pemt+/+ mice. 
 
Supplemental Figure 2. Metabolic data of Pemt+/+, Pemt+/-, Pemt-/- mice under 
standard (STD) and high fat-high sucrose (HFHS) diet at 25 weeks of age. a. ad Librium 
Blood glucose. b. Fasting blood glucose. c. Serum total cholesterol. d. Serum triglyceride. e. 
Serum adiponectin levels. f. Serum leptin levels. All data are presented as mean ± SE. n 
=5-6. *P < 0.05, **P < 0.01. 
 
Supplemental Figure 3. Macrophage infiltration and expression of fibrogenic 
molecules in the liver under high fat-high sucrose (HFHS) diets. a. Immunostaining of 
F4/80. Bar=100 μm. b. Western blot analyses of liver samples.    
 
Supplemental Figure 4. Electron micrograph of hepatocytes in Pemt+/+ and Pemt-/- 
fed with high fat-high sucrose (HFHS) diets at 25 weeks of age. a. Marked deposition of 
glycogen granules (asterisk) in Pemt+/+ mice under HFHS diet. b. Apparently large lipid 
droplets (L) and decreased glycogen granules in Pemt-/- mice under HFHS diet. c. 
Prominent rough endoplasmic reticulum (ER) with lamellar structure in Pemt+/+ mice under 
HFHS diet. d. Numerous large mitochondria (M) and round-shaped smooth ER in Pemt-/- 
mice. 
 
Supplemental Figure 5. Western blotting analyses of H-4-II-E-C-3 cells treated with 
shRNA-CTRL or shRNA-Pemt. Insulin-induced up-regulation of pro-apoptotic cleaved 
caspases 3 and 7 are suppressed and anti-apoptotic Akt phosphorylation is enhanced by 
knockdown of Pemt. Palmitate-induced pro-apoptotic molecules, cleaved caspases 3 and 7, 
increased in shRNA-PEMT-treated cells. NG; normal glucose (5 mM), HG; high glucose (25 
mM). 
 
Supplemental Figure 6. Interaction of Pemt with clathrin heavy chain (CHC) and 
Pemt-CHC-p53 tri-complex formation. a. Immunoprecipitation using COS-7 cells 
expressing FLAG-Pemt and myc-CHC. FLAG-Pemt interacts with p53-binding (1074-1406) 
and clathrin light chain-binding (1267-1513) domains of CHC tagged with myc-epitope. b. 
Immunoprecipitation of nuclear lysates of NIN3T3 cells with anti-p53 antibodies. The 
formation of p53 and Pemt complex is confirmed. c. Immunoprecipitation of nuclear proteins 
of liver tissues with anti-p53 antibodies. The complex formation is also confirmed in liver 
tissues. 
 
Supplemental Figure 7. Down-regulation of clathrin heacy chain (CHC) by 
overexpression of Pemt. COS-7 cells were transfected with FLAG-Pemt and myc-CHC in 
different concentrations. a. Incremental doses of myc-CHC upregulates the expression of 
FLAG-Pemt. b. The expression of CHC is suppressed by overexpression of FLAG-Pemt in a 
dose-dependent manner. c. Western blot analysis of liver protein of Pemt+/+, Pemt+/-, 
Pemt-/- mice under standard (STD) or high fat-high sucrose (HFHS) diet at 25 weeks of age. 
The expression of CHC increased under HFHS diet and further enhanced by deficiency of 
Pemt. d. Western blot analysis of liver nuclear protein. Liver tissues were excised out at 15 
minutes after intraperitoneal injection of 5 units of human insulin and the nuclear proteins 
were extracted from Pemt+/+ mice under STD or HFHS diet at 25 weeks of age.  
 
Supplemental Figure 8. UCSC genome browser view showing the methylation status 
of F-box only protein 31 (Fbxo31). Model-based Analysis of ChIP-Seq 
(MACS)_peak_1995 (Red square) is one of the enrichment regions listed on Supplemental 
Table 2. At this region, the sequence depth of genomic DNA methylation of Pemt-/- mice 
(Blue) under high fat-high sucrose diet at 25 weeks of old was significantly increased 
compared to Pemt+/+ mice (Dark red).  
 
Supplemental Figure 9. UCSC genome browser view showing the methylation status 
of hepatocyte nuclear factor 4 alpha (HNF4α). Model-based Analysis of ChIP-Seq 
(MACS)_peak_1221 (Red square) is one of the enrichment regions listed on Supplemental 
Table 2. At this region, the sequence depth of genomic DNA methylation of Pemt-/- mice 
(Blue) under high fat-high sucrose diet at 25 weeks of old was significantly increased 
compared to Pemt+/+ mice (Dark red). 
 
Supplemental Figure 10. Pemt mRNA expression in Japanese patients with 
non-alcoholic steatohepatitis and simple steatosis. The patients were divided into 
quartile (Q1, Q2, Q3 and Q4) according to Pemt mRNA levels of liver samples. Lower 
quartile of Pemt mRNA (Q2) demonstrated lower body-mass-index (BMI) and platelet counts. 
All data are means ± SE. n=8 (Q1), 8 (Q2), 10 (Q3), 8 (Q4). *P < 0.05. 
 
Supplemental Figure 11 Uncropped images for the blots shown in Figure 4. 
Supplemental Figure 12 Uncropped images for the blots shown in Figures 5 and 6. 
Supplemental Figure 13 Uncropped images for the blots shown in Figure S3. 
Supplemental Figure 14 Uncropped images for the blots shown in Figure S5. 
Supplemental Figure 15 Uncropped images for the blots shown in Figure S5. 
Supplemental Figure 16 Uncropped images for the blots shown in Figure S7. 
Supplemental Figure 17 Uncropped images for the blots shown in Figure 8. 
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Figure 5 Original figure
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Supplementary Table 2 List of genes with hypermethylated genomic DNA and reduced mRNA expression in Pemt-/- mice compared to Pemt+/+ fed high fat-high sucrose chow.
Region_name Position Length Summit Tags -10log10(pvalue) Fold_enrichmentFDR(%) RefseqID Status GeneID Symbol Definition Distance(bp) 1 week 2 week 3 week 4 week Pearson correlationcoefficient of determination
MACS_peak_1437 chr4:88335056-88335560 505 128 9 55 16.42 100 NM_010503.2 UP 15965 Ifna2 interferon alpha 2 5373 0.83 0.91 0.41 0.24 -0.23 0.39
MACS_peak_845 chr17:12766866-12767234 369 166 9 56.23 10.84 100 NM_013667.2 UP 20518 Slc22a2 solute carrier family 22 (organic cation transporter), member 2 9820 0.91 0.61 0.1 0.33 -0.23 0.87
MACS_peak_788 chr16:33621596-33621937 342 149 17 83.26 10.6 100 NM_134251.2 INCLUDE 171286 Slc12a8 solute carrier family 12 (potassium/chloride transporters), mem 0 0.91 0.96 0.34 0.49 -0.19 0.82
MACS_peak_112 chr1:176979729-176980084 356 194 9 53.19 11.03 100 NM_011880.3 DOWN 24012 Rgs7 regulator of G protein signaling 7 9122 0.71 0.43 0.45 0.1 -0.18 0.16
MACS_peak_1221 chr2:163375130-163375391 262 131 9 59.3 9.13 100 NM_008261.2 INCLUDE 15378 Hnf4a hepatic nuclear factor 4, alpha 0 0.97 0.61 0.69 0.42 -0.16 0.75
MACS_peak_249 chr10:127159015-127159368 354 176 10 76.55 15.49 100 NM_009312.2 UP 21334 Tac2 tachykinin 2 3079 0.76 0.19 0.62 0.1 -0.16 0.00
MACS_peak_1206 chr2:155361261-155361697 437 207 8 51.46 12.31 100 NM_019811.3 INCLUDE 60525 Acss2 acyl-CoA synthetase short-chain family member 2 0 0.51 0.59 0.23 0.17 -0.14 0.69
MACS_peak_1995 chr8:124066250-124066683 434 222 11 52.71 8.96 100 NM_133765.3 DOWN 76454 Fbxo31 F-box protein 31 9195 0.79 0.69 0.36 0.44 -0.14 0.79
MACS_peak_1348 chr3:135486084-135486497 414 258 9 62.6 16.42 100 NM_026228.4 UP 67547 Slc39a8 solute carrier family 39 (metal ion transporter), member 8 1957 0.89 0.98 0.73 0.54 -0.13 0.62
MACS_peak_734 chr15:85868509-85868805 297 148 9 78.57 17.43 100 NM_009886.2 UP 12614 Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo ho 4302 0.99 0.67 0.63 0.62 -0.12 0.06
MACS_peak_1879 chr7:150614220-150614703 484 111 9 53.19 11.25 100 NM_008434.2 DOWN 16535 Kcnq1 potassium voltage-gated channel, subfamily Q, member 1 1273 0.43 0.79 0.5 0.24 -0.09 0.77
MACS_peak_1133 chr2:69130200-69130511 312 156 13 56.57 7.85 100 NM_021022.3 INCLUDE 27413 Abcb11 ATP-binding cassette, sub-family B (MDR/TAP), member 11 0 0.77 0.84 0.66 0.56 -0.08 0.24
MACS_peak_190 chr10:70687437-70687775 339 186 8 51.22 11.07 100 NM_009360.4 DOWN 21780 Tfam transcription factor A, mitochondrial 449 0.98 0.93 0.75 0.81 -0.07 0.75
MACS_peak_1209 chr2:155720125-155720649 525 123 13 57.95 11.07 100 NM_018888.3 INCLUDE 56046 Uqcc ubiquinol-cytochrome c reductase complex chaperone, CBP3 h 0 0.95 0.84 0.98 0.69 -0.06 0.71
MACS_peak_1976 chr8:106639382-106639891 510 372 13 53.79 11.85 100 NM_009868.4 INCLUDE 12562 Cdh5 cadherin 5 0 0.88 0.53 0.45 0.72 -0.06 0.40
MACS_peak_1894 chr8:13072286-13072668 383 234 18 75.95 10.09 100 NM_025834.3 INCLUDE 66901 Proz protein Z, vitamin K-dependent plasma glycoprotein 0 0.77 0.81 0.71 0.65 -0.05 0.72
MACS_peak_1538 chr5:49120965-49121544 580 445 14 59.23 12 100 NM_030265.3 INCLUDE 80334 Kcnip4 Kv channel interacting protein 4 0 0.48 0.56 0.48 0.37 -0.04 0.01
MACS_peak_1840 chr7:104561691-104562174 484 299 15 68.01 10.31 100 NM_009381.2 INCLUDE 21835 Thrsp thyroid hormone responsive SPOT14 homolog (Rattus) 0 0.24 0.23 0.36 0.08 -0.04 0.46
MACS_peak_849 chr17:15607555-15607935 381 213 16 62.14 8.26 100 NM_011185.3 DOWN 19170 Psmb1 proteasome (prosome, macropain) subunit, beta type 1 4749 0.95 0.97 0.83 0.88 -0.04 0.14
MACS_peak_623 chr14:66708189-66708460 272 136 9 89.25 17.43 100 NM_007940.3 INCLUDE 13850 Ephx2 epoxide hydrolase 2, cytoplasmic 0 0.62 0.75 0.56 0.58 -0.03 0.71
MACS_peak_1290 chr3:82806528-82806936 409 152 11 70.81 14.26 100 NM_133862.1 UP 99571 Fgg fibrinogen gamma chain 4881 0.72 0.83 0.64 0.68 -0.03 0.72
MACS_peak_2045 chr9:53256040-53256403 364 209 20 57.15 5.99 100 NM_007499.2 INCLUDE 11920 Atm ataxia telangiectasia mutated homolog (human) 0 0.99 0.86 0.94 0.87 -0.03 0.07
MACS_peak_1341 chr3:129561307-129561910 604 460 32 51.26 5.72 100 NM_007686.2 INCLUDE 12630 Cfi complement component factor i 0 0.71 0.85 0.7 0.67 -0.03 0.25
MACS_peak_1616 chr5:130559279-130559562 284 142 10 62.89 11 100 NM_013837.1 INCLUDE 22021 Tpst1 protein-tyrosine sulfotransferase 1 0 0.81 0.67 0.76 0.7 -0.02 0.02
MACS_peak_542 chr13:94428836-94429076 241 120 8 53.57 7.12 100 NM_022884.2 INCLUDE 64918 Bhmt2 betaine-homocysteine methyltransferase 2 0 0.78 0.86 0.77 0.73 -0.02 0.35
MACS_peak_127 chr1:194304163-194304446 284 142 9 54.64 9.9 100 NM_010600.2 INCLUDE 16510 Kcnh1 potassium voltage-gated channel, subfamily H (eag-related), me 0 0.36 0.08 0.32 0.2 -0.02 0.02
MACS_peak_1812 chr7:70799899-70800347 449 324 8 50.54 12.31 100 NM_130880.1 INCLUDE 170711 Otud7a OTU domain containing 7A 0 0.65 0.97 0.95 0.58 -0.02 0.03
MACS_peak_687 chr15:27524249-27524604 356 166 10 52.79 9.96 100 NM_020332.4 INCLUDE 11732 Ank progressive ankylosis 0 0.95 0.68 0.84 0.82 -0.02 0.49
MACS_peak_251 chr10:128367392-128367607 216 108 8 58.32 6.69 100 NM_015740.3 UP 14533 Bloc1s1 biogenesis of lysosome-related organelles complex-1, subunit 1 6812 0.85 0.99 0.89 0.81 -0.02 0.22 　
MACS_peak_1166 chr2:103294602-103295091 490 237 28 85.3 7.21 100 NM_009804.2 INCLUDE 12359 Cat catalase 0 0.75 0.75 0.67 0.73 -0.01 0.32
MACS_peak_662 chr15:3350375-3350642 268 134 8 52.3 8.3 100 NM_010284.2 INCLUDE 14600 Ghr growth hormone receptor 0 0.51 0.9 0.57 0.58 -0.01 0.19 　
MACS_peak_435 chr12:86616008-86616294 287 143 9 55.07 10 100 NM_025421.2 INCLUDE 66204 Acyp1 acylphosphatase 1, erythrocyte (common) type 0 0.97 0.77 0.9 0.89 -0.01 0.24
MACS_peak_1205 chr2:155011673-155011909 237 118 12 78.87 7.34 100 NM_008395.2 INCLUDE 16396 Itch itchy, E3 ubiquitin protein ligase 0 0.96 0.88 0.87 0.93 -0.01 0.14
MACS_peak_1180 chr2:118364973-118365318 346 160 9 51.79 10.33 100 NM_138313.3 INCLUDE 171543 Bmf BCL2 modifying factor 0 0.44 0.06 0.85 0.15 -0.01 0.09
MACS_peak_2037 chr9:45721993-45722285 293 146 8 70.55 16.42 100 NM_008794.2 INCLUDE 18554 Pcsk7 proprotein convertase subtilisin/kexin type 7 0 0.9 0.98 0.98 0.88 -0.01 0.23
MACS_peak_994 chr18:61449422-61449852 431 216 16 62.14 7.34 100 NM_133249.2 DOWN 170826 Ppargc1b peroxisome proliferative activated receptor, gamma, coactivator 7937 0.54 0.55 0.53 0.53 -0.01 0.02
MACS_peak_1158 chr2:94248499-94248890 392 118 9 53.19 10.63 100 NM_007466.2 DOWN 11800 Api5 apoptosis inhibitor 5 2993 0.91 0.94 0.89 0.94 0.00 0.03
MACS_peak_702 chr15:52554640-52554951 312 156 11 60.68 11.51 100 NM_027212.2 INCLUDE 69790 Med30 mediator complex subunit 30 0 0.81 0.93 0.91 0.84 0.01 0.45
MACS_peak_2142 chrX:97960347-97960667 321 160 11 68.45 13.68 100 NM_016747.2 UP 53310 Dlg3 discs, large homolog 3 (Drosophila) 2418 0.62 0.84 0.7 0.72 0.02 0.04
MACS_peak_1612 chr5:125829534-125829852 319 159 9 68.26 17.43 100 NM_016741.1 UP 20778 Scarb1 scavenger receptor class B, member 1 8090 0.76 0.93 0.81 0.86 0.02 0.03
MACS_peak_111 chr1:176819224-176819504 281 140 10 103.32 20.52 100 NM_011825.1 INCLUDE 23893 Grem2 gremlin 2 homolog, cysteine knot superfamily (Xenopus laevis) 0 0.79 0.89 0.72 0.91 0.02 0.09
MACS_peak_1104 chr2:34912635-34913053 419 141 8 52.9 12.31 100 NM_010406.1 INCLUDE 15139 Hc hemolytic complement 0 0.59 0.7 0.71 0.65 0.02 0.20
MACS_peak_946 chr18:9873595-9873967 373 215 9 53.19 10.11 100 NM_130449.2 INCLUDE 140792 Colec12 collectin sub-family member 12 0 0.78 0.67 0.67 0.85 0.02 0.12
MACS_peak_2006 chr8:129851742-129852135 394 158 10 61.82 12.21 100 NM_00112285 INCLUDE 93742 Pard3 par-3 (partitioning defective 3) homolog (C. elegans) 0 0.76 0.49 0.15 0.95 0.02 0.10
MACS_peak_1979 chr8:108094784-108095078 295 147 9 68.93 13.94 100 NM_007427.2 UP 11604 Agrp agouti related protein 2586 0.57 0.33 0.99 0.43 0.02 0.01
MACS_peak_1311 chr3:95038532-95038896 365 142 11 52.71 8.48 100 NM_134253.1 DOWN 171388 Bnipl BCL2/adenovirus E1B 19kD interacting protein like 6318 0.6 0.4 0.88 0.52 0.02 0.08
MACS_peak_908 chr17:72738020-72738230 211 105 9 112.99 14.71 100 NM_007439.2 INCLUDE 11682 Alk anaplastic lymphoma kinase 0 0.49 0.69 0.48 0.66 0.03 0.05
MACS_peak_1605 chr5:121593389-121593682 294 147 14 54.15 6.38 100 NM_00110999 INCLUDE 19247 Ptpn11 protein tyrosine phosphatase, non-receptor type 11 0 0.91 0.42 0.79 0.89 0.03 0.14
MACS_peak_1349 chr3:137881274-137881765 492 346 11 52.71 10.16 100 NM_009626.4 INCLUDE 11529 Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide 0 0.68 0.87 0.98 0.76 0.04 0.42
MACS_peak_1968 chr8:93984684-93985018 335 167 8 60.16 16.31 100 NM_011936.2 INCLUDE 26383 Fto fat mass and obesity associated 0 0.8 0.97 0.9 0.95 0.04 0.59
MACS_peak_1736 chr6:119676730-119677237 508 160 11 59.99 12.39 100 NM_053204.2 INCLUDE 111173 Erc1 ELKS/RAB6-interacting/CAST family member 1 0 0.63 0.87 0.96 0.74 0.04 0.58
MACS_peak_717 chr15:75723765-75724103 339 121 8 60.29 14.37 100 NM_023240.2 DOWN 66656 Eef1d eukaryotic translation elongation factor 1 delta (guanine nucleot 1126 0.81 0.99 0.96 0.99 0.05 0.01
MACS_peak_1299 chr3:87982310-87982778 469 321 17 68.93 10.9 100 NM_133665.3 DOWN 17261 Mef2d myocyte enhancer factor 2D 9221 0.58 0.64 0.59 0.77 0.05 0.47
MACS_peak_1220 chr2:163208420-163208736 317 158 13 50.7 7.98 100 NM_021566.1 INCLUDE 59091 Jph2 junctophilin 2 0 0.41 0.5 0.08 0.74 0.06 0.59
MACS_peak_1924 chr8:47923961-47924209 249 124 9 100.07 17.36 100 NM_008391.4 INCLUDE 16363 Irf2 interferon regulatory factor 2 0 0.68 0.64 0.88 0.83 0.07 0.12
MACS_peak_1687 chr6:58582770-58583365 596 208 15 60.77 12.7 100 NM_011920.3 INCLUDE 26357 Abcg2 ATP-binding cassette, sub-family G (WHITE), member 2 0 0.72 0.58 0.72 0.92 0.07 0.55
MACS_peak_264 chr11:11618371-11618880 510 158 12 80.15 21.73 100 NM_00102559 INCLUDE 22778 Ikzf1 IKAROS family zinc finger 1 0 0.27 0.92 0.68 0.65 0.09 0.07
MACS_peak_1689 chr6:64013625-64014102 478 325 12 60.31 11.11 100 NM_008167.2 INCLUDE 14804 Grid2 glutamate receptor, ionotropic, delta 2 0 0.62 0.62 0.6 0.97 0.10 0.84
MACS_peak_160 chr10:41906655-41907197 543 406 17 56.45 6.86 100 NM_019740.2 INCLUDE 56484 Foxo3 forkhead box O3 0 0.37 0.43 0.5 0.82 0.14 0.19
MACS_peak_281 chr11:35958621-35958974 354 192 10 59.31 11.62 100 NM_011856.3 INCLUDE 23964 Odz2 odd Oz/ten-m homolog 2 (Drosophila) 0 0.22 0.82 0.55 0.88 0.17 0.54
Tags The number of read sequences that align to a unique range of enrichment region
FDR (%) False Dicovery Rate
RedSeqID Reference sequence ID founded within 10 kbp from enrichement region
Status Positinal relationship between RefSeqID and enrichment region
Distance Lengh between RefSeq and enchment region
mRNA expression ratio (Pemt-/-(HFHS) vs Pemt+/+(HFHS)  Log2 ratio
Supplementary Table 3   
PEMT mRNA expression in livers and clinical features in SS and NASH patients 
 
  SS (n=9) NASH (n=25) P value
Age (years) 44.4 ± 11.3  50.2 ± 15.1 n.s. 
M:F 5 : 4 11 : 14  n.s. 
BMI (kg/m2) 26.8 ± 6.1  27.7 ± 5.0 n.s. 
Platelet (x104/μL) 23.6 ± 6.4  20.9 ± 8.9 n.s. 
AST (IU/L) 42.1 ± 17.8  76.9 ± 51.5 0.058 
ALT (IU/L) 69.3 ± 40.9  99.9 ± 90.1 n.s. 
γGTP (IU/L) 112.9 ± 93.2  93.3 ± 77.4 n.s. 
Total cholesterol (mg/dl) 194.8 ± 56.1  191.2 ± 54.0 n.s. 
LDL-cholesterol (mg/dl) 117.8 ± 57.1  117.0 ± 48.3 n.s. 
HDL-cholesterol (mg/dl) 56.1 ± 12.8  51.5 ± 15.7 n.s. 
Triglyceride (mg/dl) 188.2 ± 83.2  164.8 ± 85.3 n.s. 
HbA1c (%) 5.5 ± 0.4  5.6 ± 0.9 n.s. 
Fasting plasma glucose (mg/dl) 102.7 ± 8.0  109.7 ± 20.8 n.s. 
Immunoreactive insulin 10.0 ± 7.1  18.6 ± 10.7 0.014 
HOMA-IR 2.6 ± 1.9  5.5 ± 4.3 0.013 
Ferritin (ng/dl) 338.7 ± 362.7  325.6 ± 356.8 n.s. 
Liver biopsy samples     
PEMT mRNA / 18s ratio 0.95 ± 0.14  0.74 ± 0.22 0.004 
 
 
SS: simple steatosis, NASH; non-alcoholic steatohepatitis, BMI; body mass index, 











Supplementary Table 4   
PEMT mRNA expression in livers and clinical features on SS and NASH patients 
 
  SS (n=9) NASH (n=25) P value
Histological factors 
  Grade    0.006 
1 9   10      
2 0  11    
3 0  5    
4 0  0    
  Stage    0.001 
1 9 6
2 0  5    
3 0  10    
4 0  5    
  Matteoni classification    0.000 
1 6  0    
2 3  0    
3 0  0    





Supplementary Table 5   
Pearson Correlation Coefficient of PEMT mRNA expression in liver with clinical features in 
SS and NASH patients 
 
 correlation coefficient P value 
Age (years) -0.245 0.157 
BMI (kg/m2) 0.247 0.153 
Platelet (x104/μL) 0.357 0.035 
AST (IU/L) 0.095 0.586 
ALT (IU/L) 0.301 0.079 
γGTP (IU/L) 0.294 0.086 
Total cholesterol (mg/dl) -0.091 0.602 
LDL-cholesterol (mg/dl) -0.082 0.649 
HDL-cholesterol (mg/dl) -0.166 0.340 
Triglyceride (mg/dl) 0.298 0.082 
HbA1c (%) 0.138 0.431 
Fasting plasma glucose (mg/dl) -0.048 0.784 
Immunoreactive insulin -0.138 0.428 
HOMA-IR -0.183 0.300 
Ferritin (ng/dl) -0.025 0.892 
